CNM-Au8 ® treatment demonstrated significantly reduced plasma neurofilament light chain (NfL) levels compared to placebo at 24 weeks (p=0.04) Clene (CLNN) plans to discuss the totality of the survival ...

In the intent to treat analysis, Dermata saw statistically significant differences in IGA treatment success, inflammatory lesion count, and non-inflammatory lesion count at week 4 (earliest measured ...

Meta analysis in obese colorectal cancer patients found robotic assisted surgery modestly reduced hospital stay versus standard laparoscopy, with no significant differences in complications, ...

No significant differences in resistance were observed against participants with acne vulgaris (AV) against 7 antibiotics. Moreover, some resistances were seen against clindamycin, erythromycin, and ...

Dermata Therapeutics (DRMA) announced that additional analysis of topline data from its Phase 3 STAR-1 trial showed that XYNGARI had a statistically significant difference from placebo on three ...